The dysregulated probe sets corresponded to 1130 unique genes. Mutant DP cells displayed more increases than decreases of gene expression when compared with WT cells, and this was particularly striking among genes with the highest magnitude of dysregulation (Fig. 5B, right panel). Most of the dysregulated genes were causally dysregulated by the deletion of Bcl11b, estimated by the low number of false positives (“nonspecific” in Fig. 5B, estimated by performing nonspecific comparisons of the various combinations of groups comprising this website each one WT and one mutant sample). Thus, taking into account the low rate of false discovery and the redundancy among probe sets, our results indicate

that loss of Bcl11b in DP cells leads to the altered expression of approximately 1000 genes. The dysregulation of several genes identified with the Affymetrix arrays was also confirmed by RT-qPCR using independent samples (Fig. 6 and Table 1). In several cases (Zbtb7b, Runx3, CD160, and Itgb7), the real magnitude of the dysregulation

was even higher than that observed by microarray profiling (Table 1). It should be noted that lower fold changes detected by microarrays are likely to underestimate the real magnitude of the changes, especially for Buparlisib cost genes, such as Zbtb7b, which are expressed at low levels in the control samples. Pathway analyses using the Ingenuity Pathway Analysis software indicated that several gene networks were affected by Bcl11b deficiency. These included genes involved in G2/M transition, as well as signaling pathways centered on ERK, NFκB, TCR, JAK/STAT, and PI3K/AKT (Supporting Information Fig. 5). In addition, many of the genes affected by Bcl11b deficiency encode transcription factors/cofactors, which were either upregulated (Zbtb7b/ThPok, Runx3, Id2, Jun, Klf2, Lmo4, OBF-1/Pou2af1, Foxo1, Klf10, Ikzf2, NFATc2, STAT4, Lyl1, MTA1, MTA3, and the Groucho-related corepressors TLE2, TLE3 and TLE6) or down-regulated (TOX3, Ikzf3, SATB1, Klf3, Zbtb4, Jmjd3, and Sin3B), suggesting that some of the dysregulations might be secondary to the mis-expression of these factors. Among the genes strongly induced

in Bcl11b-deficient DP cells, several were known to be expressed at high levels in SP T cells and low levels in WT DP thymocytes, such as Zbtb7b and Runx3. To determine selleck compound if a mature T-cell gene expression program was prematurely induced in Bcl11b-deficient DP cells, we compared the above transcriptomic profiles with those from mature splenic CD4+ and CD8+ T cells 20. Strikingly, these analyses revealed that more than half of the probe sets dysregulated in Bcl11b-deficient DP cells, induced or repressed, displayed an expression profile closer to that of WT SP cells than DP cells (Fig. 5C, and Supporting Information Tables 1 and 2). In particular, several of the upregulated genes encode transcriptional regulators known to be critical for SP cell differentiation and/or function.